Triple Bio
PrivateLast Round
Seed
May 20, 2026
Total Funding Raised
$1.7M
Company Overview
Triple Bio is a biotechnology company that develops lipid-based feed additive platforms to improve productivity and reduce methane emissions in cattle farming.
Sector
Energy & Sustainability
Verticals
Biotechnology, Carbon Capture
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Triple Bio Comparables
Compare Triple Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Agteria Biotech | 86% | |
| Hoofprint Biome | 83% | |
| Number 8 Bio | 82% |
Triple Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 20, 2026 |
Triple Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Positron Ventures | Seed |
| Nucleus Capital | Seed |
| Climate Club | Seed |
Triple Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Triple Bio's valuation, stock price, and market status.
Is Triple Bio a public or private company?
Triple Bio is a private company.
What is the current stock price of Triple Bio?
Triple Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Triple Bio worth (valuation)?
Valuation information for Triple Bio is not publicly available.
Can I buy Triple Bio stock?
Triple Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Triple Bio's last funding round?
Triple Bio's most recent funding round was Seed on May 20, 2026.
Who are the main investors in Triple Bio?
Key investors in Triple Bio include Positron Ventures, Nucleus Capital, Climate Club.
Will Triple Bio IPO soon?
No public IPO plans have been announced for Triple Bio.
How can I track Triple Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Triple Bio's secondary market activity and sign up for updates.